David Conkling

Part of Lionbridge Technologies LLC (Delaware), ST Labs, Inc. designs and implements testing of leading edge software and emerging technology environments. The company is based in Bellevue, WA. The company was founded by Robert Arnold. ST Labs was acquired by Data Dimensions, Inc., part of Lionbridge Technologies LLC (Delaware) from June 21, 2001 on August 10, 1998 for $9.50 million.

Children's Hospital Medical Center of Akron provides health care services. It offers primary care, home care, clinical services, surgical services, and financial services. The company is headquartered in Akron, OH.

Lovelace Respiratory Research Institute provides biomedical research services. It conducts research and development of countermeasures to chemical, biological, nuclear, radiological, and explosive emerging and environmental threats to human health as well as advancing the diagnosis and treatment of mental illness and other brain disorders. The company was founded in 1947 and is headquartered in Albuquerque, NM.

RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel.

Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA.

Tisbury Pharmaceuticals Ltd. develops and markets groundbreaking therapy to treat primary open angle glaucoma. It focused on the discovery, development, and commercialization of groundbreaking therapy to treat primary open angle glaucoma. The company was founded by Andrew L. Salzman and is headquartered in Beverly, MA.

Chilmark Labs manufactures and produces rare cannabinoids. The company was founded by Andrew Salzman and is headquartered in West Tisbury, MA.

Beetlebung Pharma Ltd. focuses on the discovery and development of cannabis-related pharmaceutical therapeutics. The company was founded by Andrew Salzman on March 20, 2018 and is headquartered in Katzrin, Israel.

Cannsun Medhel Group Plc operates as a bio-pharmaceutical company. It offers cosmetics, adaptogens, women’s health, prescription and over the counter products. The company was founded by Pholoso Malatji, Nickolas Korbis and David Parry in 1918 and is headquartered in Atlantis, South Africa.

Part of Innovation1 Biotech, Inc., ST Biosciences Ltd. is a British company that engages in research and biotechnology services. The company is based in London, UK. The company was founded in 2019. ST Biosciences was acquired by Innovation1 Biotech, Inc. on November 15, 2021 for $40.65 million.